David Frazier Jarrard
机构:University of Wisconsin System, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, University of Wisconsin Health · ORCID:0000-0001-8444-7165
发表论文 407 篇 · 总被引 14304 次 · h-index 58
代表论文
- Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial (2025 · Annals of Oncology · 被引 14)
- Severe Late Toxicities (Grade 3-5) With 13 Years of Follow-up after Hypofractionated Postprostatectomy Radiotherapy (2025 · International Journal of Radiation Oncology*Biology*Physics · 被引 9)
- Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED) (2024 · European Urology Oncology · 被引 8)
- Impact of PSA nadir on long-term survival in metastatic hormone-sensitive prostate cancer: Final 10-year analysis of the ECOG-ACRIN E3805 CHAARTED trial. (2025 · Journal of Clinical Oncology · 被引 4)
- MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer (2026 · Cancer Research · 被引 2)
- Histone-modifying enzymes as drivers and therapeutic targets in androgen-resistant prostate cancer (2026 · Frontiers in Endocrinology · 被引 2)